Free fatty acids administered into the colon promote the secretion of glucagon-like peptide-1 and insulin

Biochemical and Biophysical Research Communications

Volumn 340, Issue 1, 2006, Pages 332-337

  Adachi, Tetsuya ^a   Tanaka, Toshiki ^a   Takemoto, Kazuhisa ^b   Koshimizu, Taka Aki ^a   Hirasawa, Akira ^a   Tsujimoto, Gozoh ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Diabetes mellitus; G protein coupled receptor; GLP 1; Insulin; Mouse

Indexed keywords

FATTY ACID; GLUCAGON LIKE PEPTIDE 1; INSULIN; LINOLEIC ACID; OCTANOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; INSULIN RELEASE; INTESTINE; L CELL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; COLON; DIABETES MELLITUS, TYPE 1; ENTERAL NUTRITION; FATTY ACIDS, NONESTERIFIED; GLUCAGON-LIKE PEPTIDE 1; INSULIN; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL;

ANIMALIA;

EID: 29244458142     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.11.162     Document Type: Article

References (26)

1. J.J. Holst Enteroglucagon Annu. Rev. Physiol. 59 1997 257 271
2. S. Mojsov, G.C. Weir, and J.F. Habener Glucagon-like peptide I(7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas J. Clin. Invest. 79 1987 616 619
3. T.J. Kieffer, C.H. McIntosh, and R.A. Pederson Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
4. C.F. Deacon, A.H. Johnsen, and J.J. Holst Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo J. Clin. Endocrinol. Metab. 80 1995 952 957
5. C.F. Deacon, M.A. Nauck, M. Toft-Nielsen, L. Pridal, B. Willms, and J.J. Holst Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Diabetes 44 1995 1126 1131
6. C.F. Deacon, B. Ahren, and J.J. Holst Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes? Expert Opin. Investig. Drugs 13 2004 1091 1102
7. R. Eissele, R. Goke, S. Willemer, H.P. Harthus, H. Vermeer, R. Arnold, and B. Goke Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man Eur. J. Clin. Invest. 22 1992 283 291
8. A.B. Damholt, H. Kofod, and A.M.J. Buchan Immunocytochemical evidence for paracrine interaction between GIP and GLP-1 producing cells in canine small intestine Cell Tissue Res. 298 1999 287 293
9. K. Mortensen, L.L. Christensen, and C. Orskov Colocalization of GLP-1 and GIP in human and porcine intestine Ann. N. Y. Acad. Sci. 921 2000 469 472
10. K. Mortensen, L.L. Christensen, J.J. Holst, and C. Orskov GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine Regul. Pept. 114 2003 189 196
11. J.N. Roberge, and P.L. Brubaker Secretion of proglucagon-derived peptides in response to intestinal luminal nutrients Endocrinology 128 1991 3169 3174
12. J.N. Roberge, and P.L. Brubaker Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop Endocrinology 133 1993 233 240
13. V. Dumoulin, T. Dakka, P. Plaisancie, J.-A. Chayvialle, and J.-C. Cuber Regulation of glucagon-like peptide-1-(7-36)amide, peptide YY, and neurotensin secretion by neurotransmitters and gut hormones in the isolated vascularly perfused rat ileum Endocrinology 139 1998 3780 3786
14. A.S. Rocca, and P.L. Brubaker Role of the vagus nerve in mediating proximal nutrient-induced glucagons-like peptide-1 secretion Endocrinology 140 1999 1687 1694
15. A.S. Rocca, J. LaGreca, J. Kalitsky, and P.L. Brubaker Monosaturated fatty acid diets improve glycemic tolerance through increased secretion of glucagon-like peptide-1 Endocrinology 142 2001 1148 1155
16. A. Hirasawa, K. Tsumaya, T. Awaji, S. Katsuma, T. Adachi, M. Yamada, Y. Sugimoto, S. Miyazaki, and G. Tsujimoto Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat. Med. 11 2005 90 94
17. H. Ueda, H. Ikegami, E. Yamato, J. Fu, M. Fukuda, G. Shen, Y. Kawaguchi, K. Takekawa, Y. Fujioka, and T. Fujisawa The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity Diabetologia 38 1995 503 508
18. Y. Hamada, H. Ikegami, H. Ueda, Y. Kawaguchi, E. Yamato, K. Nojima, K. Yamada, N. Babaya, M. Shibata, and T. Ogihara Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice Metabolism 50 2001 1282 1285
19. R.A. Pederson, H.A. White, D. Schlenzig, R.P. Pauly, C.H. McIntosh, and H.U. Demuth Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide Diabetes 47 1998 1253 1258
20. R. Burcelin The incretin: a link between nutrients and well-being Br. J. Nutr. 93 2005 S147 S156
21. M. Perley, and D. Kpnis Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects J. Clin. Invest. 46 1967 1954 1962
22. T. Nagakura, N. Yasuda, K. Yamazaki, H. Ikuta, and I. Tanaka Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition Metabolism 52 2003 81 86
23. J. Schirra, and B. Goke The physiological role of GLP-1 in human: incretin, ileal brake or more? Regul. Pept. 128 2005 109 115
24. R.M. Elliott, L.M. Morgan, J.A. Tredger, S. Deacon, J. Wright, and V. Marks Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24-h secretion patterns J. Endocrinol. 138 1993 159 166
25. C. Herrmann, R. Goke, G. Richter, H.C. Fehmann, R. Arnold, and B. Goke Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients Digestion 56 1995 117 126
26. E. Rask, T. Olsson, S. Soderberg, O. Johnson, J. Seckl, J.J. Holst, and B. Ahren Northern Sweden Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA), impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men Diabetes Care 24 2001 1640 1645